SCHEMBL19787372

SCHEMBL19787372

COc1ccc(/C=C\C(F)(F)F)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 3/20 0.64
KDM4E B2RXH2 3/20 0.57
CYP3A4 P08684 2/20 0.57
LMNA P02545 2/20 0.57
TP53 P04637 1/20 0.57
TSHR P16473 1/20 0.57
ALDH1A1 P00352 1/20 0.57
RELA Q04206 3/20 0.55
TRPA1 O75762 1/20 0.55
CYP1A2 P05177 3/20 0.53
CYP1A1 P04798 3/20 0.53
CYP1B1 Q16678 3/20 0.53
ESR1 P03372 2/20 0.53
PTGS2 P35354 2/20 0.53
NQO2 P16083 2/20 0.53
AHR P35869 2/20 0.53
ABL1 P00519 1/20 0.53
TTR P02766 1/20 0.53
ABCB1 P08183 1/20 0.53
ALOX5 P09917 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12028758 0.81 KDM4E (0.59) NFE2L2KDM4ECYP3A4LMNATP53
SCHEMBL678598 0.81 KDM4E (0.59) NFE2L2KDM4ECYP3A4LMNATP53
SCHEMBL14950253 0.79 RELA (0.81) NFE2L2KDM4ECYP3A4LMNATP53
SCHEMBL699457 0.79 RELA (0.81) NFE2L2KDM4ECYP3A4LMNATP53
SCHEMBL631998 0.79 RELA (0.81) NFE2L2KDM4ECYP3A4LMNATP53
SCHEMBL13790336 0.79 RELA (0.81) NFE2L2KDM4ECYP3A4LMNATP53
SCHEMBL699458 0.79 RELA (0.81) NFE2L2KDM4ECYP3A4LMNATP53
SCHEMBL4881152 0.79 RELA (0.81) NFE2L2KDM4ECYP3A4LMNATP53
SCHEMBL28891539 0.79 CYP1A1 (0.64) KDM4EALDH1A1CYP1A2CYP1A1CYP1B1
SCHEMBL8059285 0.78 ALDH1A1 (0.52) NFE2L2KDM4ECYP3A4LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11020730-B2 Halogen-containing metathesis catalysts and methods thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-06-01 US disclosed
US-20190314799-A1 HALOGEN-CONTAINING METATHESIS CATALYSTS AND METHODS THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2019-10-17 US disclosed
WO-2018013943-A1 HALOGEN-CONTAINING METATHESIS CATALYSTS AND METHODS THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190314799-A1 HALOGEN-CONTAINING METATHESIS CATALYSTS AND METHODS THEREOF ZRANB2, SLC39A3, ZCCHC8 NFE2L2 562/4885KDM4E 3878/4885CYP3A4 698/4885
US-11020730-B2 Halogen-containing metathesis catalysts and methods thereof ZRANB2, SLC39A3, ZCCHC8 NFE2L2 562/4885KDM4E 3878/4885CYP3A4 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.